# LYPLAL1

## Overview
LYPLAL1 (lysophospholipase like 1) is a gene that encodes a protein involved in lipid metabolism, specifically functioning as a triglyceride lipase. The LYPLAL1 protein is categorized as a lipase and is primarily active in the cytoplasm, where it is implicated in the breakdown of lysophospholipids, components of cell membranes that play a role in signaling pathways (Bille2011Implications). This protein is thought to influence adipocyte differentiation and energy homeostasis, thereby impacting fat distribution and metabolic processes within the body (Bille2011Implications). Genetic variations in LYPLAL1 have been associated with metabolic traits such as central obesity and insulin resistance, particularly in females, suggesting its significant role in metabolic regulation and potential as a therapeutic target for metabolic disorders (Bille2011Implications; Vohnoutka2023Knockout).

## Structure


## Function
LYPLAL1 (lysophospholipase like 1) is a gene that encodes a protein involved in lipid metabolism, specifically thought to function as a triglyceride lipase. This protein is active in the cytoplasm and may play a role in adipocyte differentiation and energy homeostasis, impacting fat distribution and metabolic processes in the body (Bille2011Implications). The LYPLAL1 protein is believed to influence the breakdown of lysophospholipids, which are components of cell membranes and play a role in signaling pathways (Bille2011Implications).

In healthy human cells, LYPLAL1 is associated with central obesity and metabolic traits. The major G-allele of rs2605100 in LYPLAL1 has been linked to increased waist-hip ratio among women and is associated with elevated fasting serum triglycerides and insulin levels, as well as central obesity (Bille2011Implications). These associations suggest that LYPLAL1 may contribute to lipid metabolism and insulin signaling, potentially influencing insulin resistance and obesity-related traits (Bille2011Implications). However, further research is needed to fully understand the gene's function and its contribution to the pathophysiology of obesity (Bille2011Implications).

## Clinical Significance
Mutations and alterations in the expression of the LYPLAL1 gene have been associated with several metabolic conditions, particularly obesity and related disorders. In humans, single nucleotide polymorphisms (SNPs) near the LYPLAL1 gene are linked to obesity, with a more pronounced effect observed in females. These genetic variations are also associated with altered fat distribution, influencing the visceral to subcutaneous adipose tissue ratio and waist-to-hip ratio, which are critical factors in obesity-related health risks (Burgdorf2011Association; Vohnoutka2023Knockout).

The LYPLAL1 gene may also play a role in non-alcoholic fatty liver disease (NAFLD). Although its function in NAFLD is not fully understood, LYPLAL1 variants have been implicated in hepatic glucose metabolism and lipogenesis pathways, potentially contributing to fatty liver development (Sliz2018NAFLD). In mice, knockout studies of the Lyplal1 gene have shown sex-specific protection against diet-induced obesity and liver steatosis, suggesting that LYPLAL1 may influence fat distribution and liver health through mechanisms that differ between sexes (Vohnoutka2023Knockout).

Additionally, LYPLAL1 has been studied in the context of non-small cell lung cancer (NSCLC), where its suppression was found to reduce cell proliferation, migration, and invasion, indicating a potential role in cancer progression (Mohammed2018Inhibition).

## Interactions
LYPLAL1, a protein involved in lipid metabolism, has been studied for its interactions with other proteins and its role in metabolic processes. The enzyme LYPLAL1 is activated by small-molecule compounds, such as PAL-4, which were identified through activity-based protein profiling. These activators enhance LYPLAL1 activity, suggesting potential interactions with other proteins involved in metabolic pathways (Kok2020Discovery).

In the context of genetic studies, LYPLAL1 has been associated with metabolic traits, including obesity and fat distribution. Variants in the LYPLAL1 gene have been linked to waist-hip ratio and lipid metabolism, indicating its involvement in complex metabolic networks (Bille2011Implications; HernándezTobías2016PPARGLYPLAL1).

Research on LYPLAL1 knockout mice has revealed sex-specific effects on fat deposition and metabolism, suggesting that LYPLAL1 may interact with sex hormones or their receptors, such as estrogen receptors, to influence metabolic outcomes. This interaction could be a factor in the observed differences in fat distribution and metabolic traits between male and female mice (Vohnoutka2023Knockout).

Overall, LYPLAL1's interactions with small molecules and potential involvement in hormone-related pathways highlight its significance in metabolic regulation and its potential as a therapeutic target for metabolic disorders.


## References


[1. (Bille2011Implications) Dorthe S. Bille, Karina Banasik, Johanne M. Justesen, Camilla H. Sandholt, Annelli Sandbæk, Torsten Lauritzen, Torben Jørgensen, Daniel R. Witte, Jens-Christian Holm, Torben Hansen, and Oluf Pedersen. Implications of central obesity-related variants in lyplal1, nrxn3, msra, and tfap2b on quantitative metabolic traits in adult danes. PLoS ONE, 6(6):e20640, June 2011. URL: http://dx.doi.org/10.1371/journal.pone.0020640, doi:10.1371/journal.pone.0020640. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0020640)

[2. (Vohnoutka2023Knockout) Rishel B Vohnoutka, Annapurna Kuppa, Yash Hegde, Yue Chen, Asmita Pant, Maurice E Tohme, Eun-Young (Karen) Choi, Sean M McCarty, Devika P Bagchi, Xiaomeng Du, Yanhua Chen, Vincent L Chen, Hiroyuki Mori, Lawrence F Bielak, Lillias H Maguire, Samuel K Handelman, Jonathan Z Sexton, Thomas L Saunders, Brian D Halligan, and Elizabeth K Speliotes. Knockout of murine lyplal1 confers sex-specific protection against diet-induced obesity. Journal of Molecular Endocrinology, February 2023. URL: http://dx.doi.org/10.1530/jme-22-0131, doi:10.1530/jme-22-0131. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/jme-22-0131)

[3. (HernándezTobías2016PPARGLYPLAL1) Esther-Alhelí Hernández-Tobías, Luisa Torres-Sánchez, Gino Noris, Carla Santana, Maria Reyna Samano, José Arellano-Galindo, María de la Luz Arenas-Sordo, Daniel Brooks, Ana Lilia Rodríguez-Ventura, Marco Antonio Meraz-Ríos, and Rocío Gómez. Pparg-lyplal1 multi-allelic combination associated with obesity and overweight in mexican adolescent females. Ethnicity &amp; Disease, 26(4):477, October 2016. URL: http://dx.doi.org/10.18865/ED.26.4.477, doi:10.18865/ed.26.4.477. This article has 5 citations.](https://doi.org/10.18865/ED.26.4.477)

[4. (Sliz2018NAFLD) Eeva Sliz, Sylvain Sebert, Peter Würtz, Antti J Kangas, Pasi Soininen, Terho Lehtimäki, Mika Kähönen, Jorma Viikari, Minna Männikkö, Mika Ala-Korpela, Olli T Raitakari, and Johannes Kettunen. Nafld risk alleles in pnpla3, tm6sf2, gckr and lyplal1 show divergent metabolic effects. Human Molecular Genetics, 27(12):2214–2223, April 2018. URL: http://dx.doi.org/10.1093/hmg/ddy124, doi:10.1093/hmg/ddy124. This article has 97 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddy124)

[5. (Kok2020Discovery) Bernard P. Kok, Srijana Ghimire, Woojoo Kim, Shreyosree Chatterjee, Tyler Johns, Seiya Kitamura, Jerome Eberhardt, Daisuke Ogasawara, Janice Xu, Ara Sukiasyan, Sean M. Kim, Cristina Godio, Julia M. Bittencourt, Michael Cameron, Andrea Galmozzi, Stefano Forli, Dennis W. Wolan, Benjamin F. Cravatt, Dale L. Boger, and Enrique Saez. Discovery of small-molecule enzyme activators by activity-based protein profiling. Nature Chemical Biology, 16(9):997–1005, June 2020. URL: http://dx.doi.org/10.1038/s41589-020-0555-4, doi:10.1038/s41589-020-0555-4. This article has 35 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41589-020-0555-4)

[6. (Burgdorf2011Association) K. S. Burgdorf, A. P. Gjesing, N. Grarup, J. M. Justesen, C. H. Sandholt, D. R. Witte, T. Jørgensen, S. Madsbad, T. Hansen, and O. Pedersen. Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 danish individuals. Diabetologia, 55(1):105–113, September 2011. URL: http://dx.doi.org/10.1007/s00125-011-2320-4, doi:10.1007/s00125-011-2320-4. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-011-2320-4)

[7. (Mohammed2018Inhibition) Anaz Mohammed, Caixin Zhang, Shuwen Zhang, Qin Shen, Jieying Li, Zhiyuan Tang, and Hua Liu. Inhibition of cell proliferation and migration in non‑small cell lung cancer cells through the suppression of lypla1. Oncology Reports, November 2018. URL: http://dx.doi.org/10.3892/or.2018.6857, doi:10.3892/or.2018.6857. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2018.6857)